These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 8750184)

  • 1. Expression of CD44 splice variants in human primary brain tumors.
    Kaaijk P; Troost D; Morsink F; Keehnen RM; Leenstra S; Bosch DA; Pals ST
    J Neurooncol; 1995 Dec; 26(3):185-90. PubMed ID: 8750184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of variant CD44 epitopes in human astrocytic brain tumors.
    Eibl RH; Pietsch T; Moll J; Skroch-Angel P; Heider KH; von Ammon K; Wiestler OD; Ponta H; Kleihues P; Herrlich P
    J Neurooncol; 1995 Dec; 26(3):165-70. PubMed ID: 8750182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schwann cell tumors express characteristic patterns of CD44 splice variants.
    Sherman L; Skroch-Angel P; Moll J; Schwechheimer K; Ponta H; Herrlich P; Hofmann M
    J Neurooncol; 1995 Dec; 26(3):171-84. PubMed ID: 8750183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of CD44 in the invasiveness of glioblastoma multiforme and the noninvasiveness of meningioma: an immunohistochemistry study.
    Ariza A; López D; Mate JL; Isamat M; Musulén E; Pujol M; Ley A; Navas-Palacios JJ
    Hum Pathol; 1995 Oct; 26(10):1144-7. PubMed ID: 7557949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of CD44 splice variants in formalin-fixed, paraffin-embedded specimens of human skin cancer.
    Dietrich A; Tanczos E; Vanscheidt W; Schöpf E; Simon JC
    J Cutan Pathol; 1997 Jan; 24(1):37-42. PubMed ID: 9027631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapeutic approaches to primary and metastatic brain tumors: II. ribozyme-mediated suppression of CD44 expression.
    Ge L; Resnick NM; Ernst LK; Salvucci LA; Asman DC; Cooper DL
    J Neurooncol; 1995 Dec; 26(3):251-7. PubMed ID: 8750191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expressions of CD44 variants in tumors affecting the central nervous system.
    Resnick DK; Resnick NM; Welch WC; Cooper DL
    Mol Diagn; 1999 Sep; 4(3):219-32. PubMed ID: 10553022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CD44 splice variants in human cutaneous melanoma and melanoma cell lines is related to tumor progression and metastatic potential.
    Manten-Horst E; Danen EH; Smit L; Snoek M; Le Poole IC; Van Muijen GN; Pals ST; Ruiter DJ
    Int J Cancer; 1995 Jun; 64(3):182-8. PubMed ID: 7542641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD44 splice variants in human skin and epidermal tumours.
    Seiter S; Tilgen W; Herrmann K; Schadendorf D; Patzelt E; Möller P; Zöller M
    Virchows Arch; 1996 Jun; 428(3):141-9. PubMed ID: 8688968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of CD44 splice variants in human stage III cervical cancer.
    Kainz C; Kohlberger P; Tempfer C; Sliutz G; Gitsch G; Reinthaller A; Breitenecker G
    Eur J Cancer; 1995 Sep; 31A(10):1706-9. PubMed ID: 7488429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variant CD44 adhesion molecules are expressed in human brain metastases but not in glioblastomas.
    Li H; Hamou MF; de Tribolet N; Jaufeerally R; Hofmann M; Diserens AC; Van Meir EG
    Cancer Res; 1993 Nov; 53(22):5345-9. PubMed ID: 7693337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44 splice variant expression in clear cell carcinoma of the ovary.
    Rodríguez-Rodríguez L; Sancho-Torres I; Leakey P; Gibbon DG; Comerci JT; Ludlow JW; Mesonero C
    Gynecol Oncol; 1998 Nov; 71(2):223-9. PubMed ID: 9826464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44 and variants in melanocytic skin neoplasms.
    Schaider H; Soyer HP; Heider KH; Hofmann-Wellenhof R; Zatloukal K; Smolle J; Kerl H
    J Cutan Pathol; 1998 Apr; 25(4):199-203. PubMed ID: 9609138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of the human metastasis adhesion molecule CD44V in normal and carcinomatous stomach mucosa of Chinese subjects.
    Harn HJ; Ho LI; Chang JY; Wu CW; Jiang SY; Lee HS; Lee WH
    Cancer; 1995 Mar; 75(5):1065-71. PubMed ID: 7531611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44 expression in astrocytic tumors.
    Ylagan LR; Quinn B
    Mod Pathol; 1997 Dec; 10(12):1239-46. PubMed ID: 9436970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 expression in human gliomas.
    Ranuncolo SM; Ladeda V; Specterman S; Varela M; Lastiri J; Morandi A; Matos E; Bal de Kier Joffé E; Puricelli L; Pallotta MG
    J Surg Oncol; 2002 Jan; 79(1):30-5; discussion 35-6. PubMed ID: 11754374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD44 isoforms and beta 1,6-branched oligosaccharides in human malignant melanoma is correlated with tumor progression but not with metastatic potential.
    Seelentag WK; Böni R; Günthert U; Futo E; Burg G; Heitz PU; Roth J
    J Cutan Pathol; 1997 Apr; 24(4):206-11. PubMed ID: 9138110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 expression in soft tissue sarcomas.
    Kahara N; Ozaki T; Doi T; Nishida K; Kawai A; Shibahara M; Inoue H
    Virchows Arch; 2000 Jun; 436(6):574-8. PubMed ID: 10917171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of epidermal growth factor receptor and CD44 splicing variants sharing exons 6 and 9 on gastric and esophageal carcinomas: a two-color flow-cytometric analysis.
    Koyama S; Maruyama T; Adachi S
    J Cancer Res Clin Oncol; 1999; 125(1):47-54. PubMed ID: 10037277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy.
    Noordzij MA; van Steenbrugge GJ; Verkaik NS; Schröder FH; van der Kwast TH
    Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.